AusBiotech Invest 2025 reposted this
AusBiotech’s Industry Growth Program (IGP) took to the BioInnovation Spotlight Stage at the AusBiotech International Conference 2025, and participated in our Innovation Activation Commercialisation Masterclass at AusBiotech Invest 2025 — part of Australia’s biggest week in biotech. As an Industry Partner Organisation (IPO) under the Australian Government's Industry Growth Program, AusBiotech delivers commercialisation advisory support for Australian biotech and medtech companies advancing through the program. At AusBiotech 2025, the IGP cohort presented to a record-breaking audience. This year's conference had more than 1,800 delegates attending throughout the week. AusBiotech Invest featured live Shark Tank-style pitches, investor insights, and leadership panels focused on commercialising Australian innovation and strengthening global readiness. A big thank you to our speakers, judges, and panellists: 🔹 Dr Nick Pachuda and Britt Koth, Precision Life Sciences & Neovate Capital (US) 🔹Helen Mutimer, Head of IP Advisory, FB Rice 🔹Dave Whelan, Bespoke Strategy (US) 🔹Mike Sewell and Robin Fieldhouse, Industry Growth Program Advisors 🔹Hayley van der Meer, Director of Membership, AusBiotech 🔹Keith Calvert, Director, Industry Growth Program 🔹Mark Harding Senior Vice President Global Marketing R&D 🔹Samantha South, Commercialisation Manager, Research Development and Innovation, Reliis 🔹Dr Marthe D'Ombrain D’Ombrain, Executive Director & Head of Global Research Innovation, CSL and AusBiotech Board member Congratulations to all pitching companies for their outstanding presentations across the week. Led by Tamlyn O'Connor it was an inspiring week connecting innovators across the life sciences ecosystem — driving translation, development, and commercialisation from research to real-world impact. #AusBiotech2025 #LifeSciences #Biotech #Innovation #Investment Department of Industry, Science and Resources Australian Government